Literature DB >> 24870974

Highlights in metastatic breast cancer from the 2013 San Antonio Breast Cancer Symposium (SABCS).

Joyce A O'Shaughnessy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24870974

Source DB:  PubMed          Journal:  Clin Adv Hematol Oncol        ISSN： 1543-0790


× No keyword cloud information.
  2 in total

1.  A phase II clinical trial of weekly paclitaxel and carboplatin in combination with panitumumab in metastatic triple negative breast cancer.

Authors:  S Cowherd; L D Miller; S A Melin; S Akman; S Isom; J Cole; A Pullikuth; J A Lawrence
Journal:  Cancer Biol Ther       Date:  2015       Impact factor: 4.742

Review 2.  Potentiating Therapeutic Effects of Epidermal Growth Factor Receptor Inhibition in Triple-Negative Breast Cancer.

Authors:  Kyu Sic You; Yong Weon Yi; Jeonghee Cho; Jeong-Soo Park; Yeon-Sun Seong
Journal:  Pharmaceuticals (Basel)       Date:  2021-06-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.